ABEA2026: Exclusive Interview with Ms Sherry Gu, EVP & Chief Technology Officer of WuXi Biologics.

Join us for an interview with Ms Sherry Gu, EVP & Chief Technology Office at WuXi Biologics, as she reflects on winning multiple honours at the Asia-Pacific Biopharma Excellence Awards, held on 11 March in Singapore. WuXi Biologics was named winner in the following categories:

🏆Best Contract Development & Manufacturing Organization Award
🏆Best Aseptic Fill-Finish & Packaging CMO of the Year
🏆Bioprocessing Excellence in Asia
🏆Bioprocessing Excellence in China
🏆Bioprocessing Facility of the Year
🏆Excellence in Bioprocessing Automation & Digitalisation

These recognitions further reinforce WuXi Biologics’ position as a partner of choice for global biopharma innovators, with close to 1000 integrated projects across its platform, nearly half of which involve bi-/multi-specific antibodies & ADCs.

In addition to the company’s corporate honours
🏆 Dr. Sherry Gu, Chief Technology Officer & Executive Vice President, was named CTO of the Year, recognising her leadership in advancing biologics development and bioprocessing innovation.
🏆 Dr. Jeremy Guo, Senior Vice President and Head of Global Drug Product Operations, received the Head of Fill-Finish & Formulation of the Year award for his expertise in strengthening high-quality and reliable drug product manufacturing.